Posts by Sandra Ansanay-Alex
Immitra Bio Closed a CHF 2.4 Million Pre-Seed Financing Round
The ETHZ spinoff and Geneva-based company aims to replace complex stem cell transplantation procedures with a single injection, making potentially curative therapies more accessible to patients worldwide. CHF 2.25 million was provided by venture capital and private investors, with an additional CHF 150k secured through non-dilutive funding sources. The round was led by Backbone Ventures…
Read MoreActival Secures CHF 1.4 Million Innosuisse Grant
Actival, the Neuchâtel-Based medtech startup spun off from CSEM, has been awarded a CHF 1.4 million grant from Innosuisse to accelerate the development and market launch of its patented Active Splints — a new generation of patient-specific oral care devices developed in partnership with CSEM. The CHF 1.4 Million Innosuisse grant will support Actival in…
Read MoreGeneva AI Summit
The Geneva AI Summit is taking place from 21 to 22 June 2027 in Geneva. The event will bring the global conversation on artificial intelligence to the heart of multilateralism. For decades, Geneva has been a place where nations, international organizations, civil society, academia and the private sector have come together to address humanity’s most…
Read MoreUNDAE Opens Final Stage of Seed Funding Round
UNDAE, a University of Lausanne (UNIL) spinoff announces the opening of the final stage of its Seed funding round to a broader community of business angels and investors. UNDAE has developed a non-intrusive mattress topper fitted with pressure sensors. With medical-grade accuracy, it helps diagnose sleep disorders. By capturing the complexity of sleep over multiple…
Read MoreVolv Global Puts AI at the Heart of Rare Disease Diagnosis
Volv Global, healthcare AI company headquartered at Biopôle Épalinges (Vaud – Switzerland), has released two significant pieces of work in quick succession that together make a compelling case for rethinking how rare and hard-to-diagnose diseases are detected and funded. The first is a a retrospective case study applying machine learning to real-world EHR data conducted…
Read More10th Anniversary of the Center for Emerging Viral Diseases
The 10th Anniversary of the Center for Emerging Viral Diseases is taking place on 24 September 2026 at HUG in Geneva The Center for Emerging Viral Diseases is a joint institution of the Geneva University Hospitals (HUG) and the University of Geneva (UNIGE). Since its creation, the Center has established itself as a key player…
Read MoreBearmind Gets a WIPO Global Award
Bearmind swept the sport section at WIPO Global Awards on 10 July 2026. The Lausanne-based startup and EPFL spinoff is one of the eleven companies recognised worldwide. They were chosen out of 1’300 applications from 126 countries. What if your helmet could tell you when it’s time to stop? In contact sports, most head impacts go unnoticed. Bearmind helps…
Read MoreTechBio Day
TechBio Day, CSEM’s flagship bioconvergence event, is taking place in 15 September 2026 in Zürich TechBio Day is CSEM’s flagship bioconvergence event for professionals working across diagnostics, wearable health technologies, and all life sciences disciplines. This edition will be centered on the theme from point-of-care to on-body intelligence. The event explores how biology, sensing, data,…
Read MoreMATWIN Prize of the National Convention of the French Comprehensive Cancer Centres (CLCCs)
Apply before 2 September 2026 for this new distinction created by MATWIN and UNICANCER to recognise and accelerate the most promising projects in oncology research and innovation. This prize is open to start-ups, academic teams and project leaders in France, across Europe and internationally, developing solutions in the following areas: By applying for the MATWIN Prize of the National Convention of the French…
Read MoreBioAlps Welcomes HE-Arc Ingénierie: Engineering Expertise Strengthens the Swiss Health Valley
BioAlps – Western Switzerland Life Sciences Cluster is proud to announce that HE-Arc Ingénierie has officially joined the association in early June 2026, becoming its 17th research and academic institution member. HE-Arc Ingénierie is an applied research institution with 140 employees (73 FTE), an annual budget of CHF 7.4 million and over 200 active projects.…
Read More